by Erin | Sep 1, 2026 | Blog
States across the country are increasingly trying to address prescription drug affordability. In searching for solutions, some states are focusing on Medicare’s Maximum Fair Price (MFP) determination as one model for state policy action. Established under the 2022...
by Erin | Jul 17, 2026 | Blog
When Colorado defended its proposed price cap on Enbrel in federal court, it didn’t deny that someone would take a financial hit. It simply argued the hit didn’t have to land on the plaintiff in the case, the manufacturer. On July 1, 2026, a federal judge...
by Erin | Feb 18, 2026 | Blog
Polling by the Value of Care Coalition shows that when it comes to decisions about their health care, patients trust doctors (82%) — not government boards and panels (1%). If an option were included for “government officials in foreign countries,” it’s not hard to...
by Erin | Oct 22, 2025 | Blog
As states authorize and implement Prescription Drug Affordability Boards, health care stakeholders have raised concerns about both their decision-making processes and the potential negative consequences of those decisions. PDABs are inherently state-based...
